60 Degrees Pharmaceuticals (SXTP) Debt Ratio (2022 - 2025)
60 Degrees Pharmaceuticals (SXTP) has disclosed Debt Ratio for 4 consecutive years, with 0.12 as the latest value for Q3 2025.
- On a quarterly basis, Debt Ratio rose 41.8% to 0.12 in Q3 2025 year-over-year; TTM through Sep 2025 was 0.12, a 41.8% increase, with the full-year FY2024 number at 0.11, down 62.46% from a year prior.
- Debt Ratio was 0.12 for Q3 2025 at 60 Degrees Pharmaceuticals, down from 0.19 in the prior quarter.
- In the past five years, Debt Ratio ranged from a high of 1.5 in Q4 2022 to a low of 0.07 in Q1 2024.
- A 4-year average of 0.3 and a median of 0.13 in 2024 define the central range for Debt Ratio.
- Peak YoY movement for Debt Ratio: tumbled 80.23% in 2023, then soared 57.45% in 2025.
- 60 Degrees Pharmaceuticals' Debt Ratio stood at 1.5 in 2022, then crashed by 80.23% to 0.3 in 2023, then crashed by 62.46% to 0.11 in 2024, then increased by 7.12% to 0.12 in 2025.
- Per Business Quant, the three most recent readings for SXTP's Debt Ratio are 0.12 (Q3 2025), 0.19 (Q2 2025), and 0.11 (Q1 2025).